Full-root aortic valve replacement with stentless xenograft achieves superior regression of left ventricular hypertrophy compared to pericardial stented aortic valves by Reza Tavakoli et al.
Tavakoli et al. Journal of Cardiothoracic Surgery  (2015) 10:15 
DOI 10.1186/s13019-015-0219-8STUDY PROTOCOL Open AccessFull-root aortic valve replacement with stentless
xenograft achieves superior regression of left
ventricular hypertrophy compared to pericardial
stented aortic valves
Reza Tavakoli1,2*, Christoph auf der Maur3, Xavier Mueller1, Reinhard Schläpfer1, Peiman Jamshidi3,
François Daubeuf4 and Nelly Frossard4Abstract
Background: Full-root aortic valve replacement with stentless xenografts has potentially superior hemodynamic
performance compared to stented valves. However, a number of cardiac surgeons are reluctant to transform a classical
stented aortic valve replacement into a technically more demanding full-root stentless aortic valve replacement. Here
we describe our technique of full-root stentless aortic xenograft implantation and compare the early clinical and
midterm hemodynamic outcomes to those after aortic valve replacement with stented valves.
Methods: We retrospectively compared the pre-operative characteristics of 180 consecutive patients who underwent
full-root replacement with stentless aortic xenografts with those of 80 patients undergoing aortic valve replacement
with stented valves. In subgroups presenting with aortic stenosis, we further analyzed the intra-operative data, early
postoperative outcomes and mid-term regression of left ventricular mass index.
Results: Patients in the stentless group were younger (62.6 ± 13 vs. 70.3 ± 11.8 years, p < 0.0001) but had a higher
Euroscore (9.14 ± 3.39 vs.6.83 ± 2.54, p < 0.0001) than those in the stented group. In the subgroups operated for aortic
stenosis, the ischemic (84.3 ± 9.8 vs. 62.3 ± 9.4 min, p < 0.0001) and operative times (246.3 ± 53.6 vs. 191.7 ± 53.2 min, p
< 0.0001) were longer for stentless versus stented valve implantation. Nevertheless, early mortality (0% vs. 3%, p < 0.25),
re-exploration for bleeding (0% vs. 3%, p < 0.25) and stroke (1.8% vs. 3%, p < 0.77) did not differ between stentless and
stented groups. One year after the operation, the mean transvalvular gradient was lower in the stentless versus stented
group (5.8 ± 2.9 vs. 13.9 ± 5.3 mmHg, p < 0.0001), associated with a significant regression of the left ventricular mass
index in the stentless (p < 0.0001) but not in the stented group (p = 0.2).
Conclusion: Our data support that full-root stentless aortic valve replacement can be performed without adversely
affecting the early morbidity or mortality in patients operated on for aortic valve stenosis provided that the coronary
ostia are not heavily calcified. The additional time necessary for the full-root stentless compared to the classical stented
aortic valve replacement is therefore not detrimental to the early clinical outcomes and is largely rewarded in patients
with aortic stenosis by lower transvalvular gradients at mid-term and a better regression of their left ventricular
mass index.
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n = 180 n = 80
Age, years 62.6 ± 13 70.3 ± 11.8 0.0001
Female gender 49(27%) 29(36%) 0.1437
Ejection fraction 53 ± 11 55 ± 8 0.1043
Redo surgery 41(23%) 6(7.5%) 0.0032
Pathology
Aortic stenosis 75(41%) 64(80%) 0.0001
Aortic regurgitation 44(24%) 14(17.5%) 0.2158
Native endocarditis (6AS) 30(16%) 0 0.0001
Prosthetic endocarditis 14(7%) 0 0.0001
Prosthetic dysfunction 12(6%) 0 0.0001




Concomitant procedures 95(53%) 44(55%) 0.7414
Priority
Elective 108(60%) 78(97.5%) 0.0001
Urgent 50(27%) 0 0.0001
Emergency 22(13%) 2(2.5%) 0.0125
Euroscore 9.14 ± 3.39 6.83 ± 2.54 0.0001
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An increasing number of patients are requiring aortic
valve replacement, in part because of the aging population.
Biological aortic valve replacement is recommended for
patients older than 65 years [1]. Stented aortic bioprosth-
eses have been used for decades with good long-term re-
sults [2]. Yet, the ideal biological aortic valve substitute
remains a subject of debate. Aortic homografts have been
implanted by experienced surgeons with similarly excel-
lent long-term results [3]. Because of the limited availabil-
ity and the reported late degeneration of the aortic
homografts [4], stentless aortic xenografts have been de-
veloped to provide with similar hemodynamic profile and
equal or better durability. Stentless aortic xenografts can
be implanted as a subcoronary, as a root inclusion or as a
full-root aortic valve replacement [5]. Full-root replace-
ment technique has potentially superior hemodynamic
performance compared to subcoronary implantation of
stented or stentless aortic valve substitutes, since i) it of-
fers the possibility to implant a 3–4 mm larger valve in a
given patient, thus allowing significant reduction in trans-
valvular gradients resulting in a better regression of left
ventricular hypertrophy, ii) the preservation of the sinuses
of the porcine aortic root maintains an optimal coronary
perfusion, hence promoting further improvement in pa-
tient outcomes, iii) these performances apply equally to
younger patients.
Nevertheless, a number of cardiac surgeons are reluc-
tant to transform a classical aortic valve replacement
with stented biological valve into a technically more de-
manding procedure represented by full-root replacement
with stentless aortic xenografts. Moreover, there are con-
cerns regarding the increased potential for bleeding and
for possible distortion of coronary ostia anastomoses.
Here, we report our experience of full-root replacement
with stentless aortic xenografts with emphasis on the
surgical technique. In the subgroups of patients with
aortic stenosis, the early postoperative outcomes, trans-
valvular gradients and extent of regression of the left
ventricular mass index at one year post-operatively in
these patients are further compared retrospectively to
those of patients who underwent stented aortic valve im-
plantation during the same period by the same surgeon.
Methods/Design
Patient population
From January 2005 to December 2013, one hundred and
eighty patients underwent full-root replacement with
stentless porcine aortic xenografts by a single surgeon
(RT) according to the technique described here. Stent-
less aortic xenografts used were either Edwards Prima
Plus (Edwards Lifescience, Irvine, CA, USA) or Medtro-
nic Freestyle (Medtronic Inc., Minneapolis, MN, USA).
Patients’ characteristics were compared retrospectivelyto those of 80 patients who underwent aortic valve re-
placement by sternotomy with stented bovine pericardial
aortic valves (Carpentier-Edwards Perimount, Magna,
Magna ease, Edwards Lifescience, Irvine, CA, USA) dur-
ing the same period by the same surgeon (Table 1). Fur-
ther, in the subgroups of patients with aortic stenosis,
the peri-operative data and hemodynamic performance
at one year after the operation determined by echocardi-
ography were compared between the stentless and
stented cohorts. Echocardiographic data collection was
closed in December 2013. Therefore, echocardiographic
data of the patients operated in 2013 were not included
in the one-year comparison.
Surgical technique
All patients underwent median sternotomy. After
heparinization, cardiopulmonary bypass was established
between the distal ascending aorta or the right sub-
clavian artery and the right atrium or percutaneously the
femoral vein. The cardioplegic route was secured antero-
gradely (direct coronary ostia when indicated) and retro-
gradely through the coronary sinus. The ascending aorta
was cross-clamped and cold blood cardioplegia delivered
and repeated during the procedure.
Our practical approach to select the valve substitute for a
given patient was guided by the intention to achieve a
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0.85 cm2/m2 based on the EOA provided by the manu-
facturer to avoid as far as possible patient-prosthesis
mismatch (PPM). The final decision at the moment of
implantation was derived from the perceived balance
between the potentially increased peri-operative risk of
a more demanding operation represented by full-root
replacement, and the potential advantages for the pa-
tient in terms of quality of life and long-term survival.
Stentless aortic xenograft
The ascending aorta was transversally transected 1 cm-
above the right coronary ostium (Figure 1a). After in-
spection, the aortic valve was removed and the aortic
annulus prepared free as needed. The coronary ostia
were dissected free from the aortic wall with sufficient
surrounding patch, and mobilized as far as possible
(Figure 1b). The aortic stentless xenograft was im-
planted onto the surgical aortic annulus with 6 Prolene
4.0 running sutures (Figure 1c). The first suture wasFigure 1 Surgical technique of full-root aortic xenograft implantation
transected at its level to inspect the aortic valve and root (a). The aortic va
sinuses with a generous patch (b). The aortic stentless xenograft is implant
beginning under the left coronary ostium in a clockwise manner (c). The c
to avoid tension, torsion or kinking of the patient’s proximal coronary arter
anastomosis between the stentless xenograft and the mobilized distal aortplaced at the deepest point of the left coronary sinus so
that the left coronary button hole of the xenograft
exactly faced the left coronary ostium of the patient.
The suture was then run up to the commissure between
the left and right coronary sinuses and continued by a
second suture in a clockwise manner to the middle of
the right coronary sinus. Thus, each sinus of the xeno-
graft was secured to the aortic annulus with two run-
ning sutures (Figure 1c). As the height and the angle
between the native porcine coronary ostia are different
from those in the normal human anatomy, new ostia
were fashioned in the xenograft in a manner to avoid
tension, torsion or kinking of the patient’s proximal cor-
onary arteries. The angle between the coronary arteries
is more acute in porcine than in human aortic root. To
correct this mismatch, we cut the left button hole in the
xenograft rather closer to the commissure between the
left and non-coronary cusp and the right button hole in
the xenograft rather closer to the commissure between
the right and non-coronary cusp. The left button hole. The aorta is cross-clamped above the sino-tubular junction and
lve is removed and the coronary ostia are dissected free from the aortic
ed onto the surgical aortic annulus with 6 Prolene 4.0 running sutures
oronary ostia are reimplanted into the stentless xenograft in a manner
ies (d). The implantation of the xenograft is completed by end-to-end
a with a running Prolene 5.0 suture (e).
Table 2 Patient characteristics for the subgroups of
patients with aortic stenosis with or without associated






n = 68 n = 46
Age, years 59.9 ± 11.6 76.1 ± 5.7 0.0001
Female gender 19(28%) 25(54%) 0.0045
Ejection fraction 56.7 ± 8 56.5 ± 7.6 0.8936




Elective 64(94%) 46(100%) 0.0940
Euroscore 8 ± 2 7.3 ± 1.6 0.1113
Arterial hypertension 24(35%) 18(39%) 0.2011
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and the right button hole close to the free edge of the
xenograft. The coronary ostia of the patient were then at-
tached to the corresponding button hole of the xenograft
with a 6.0 Prolene running suture (Figure 1d). The im-
plantation of the xenograft was completed by end-to-end
anastomosis between the xenograft and the mobilized dis-
tal aorta with a running Prolene 5.0 suture (Figure 1e).
Heavily calcified coronary ostia represented technical limi-
tations to this technique.
Stented pericardial aortic valve
Stented valves were implanted in the subcoronary pos-
ition with pledgeted 2/0 Ethibond U-sutures (Ethicon,
Johnson&Johnson, Sollentuna, Sweden).
Echocardiographic data
Two-dimensional transthoracic echocardiography was
used to measure transvalvular gradients and left ven-
tricular mass index during the planned one-year post-
operative follow-up. Standard apical, long-axis and
short-axis views, together with Doppler flow measure-
ments were performed.
Statistical analysis
Continuous variables were expressed as means ± SD and
compared between groups using the non-parametric
Mann Whitney test. Categorical variables were expressed
as percentages and compared between groups using the
Chi-square test. Pre- versus post-operative data (LVMI)
were compared using the Wilcoxon matched-pair signed
rank test. Statistical analysis was performed using Prism
software (GraphPad, La Jolla, CA, USA), with statistical
significance set at p < 0.05.
Results
Patients’ characteristics
In the whole study population, patients in the stentless
group had a higher Euroscore although they were younger
than those in the stented group [6,7]. This was due to the
fact that there were more redo and/or urgent operations
in the former group. Aortic stenosis was the underlying
pathology in 41% of the patients in the stentless versus
80% in the stented group. Isolated aortic valve replace-
ment was performed in 47% of the patients in the stentless
and in 45% of the patients in the stented group (Table 1).
In the stentless group 75 patients had aortic stenosis. Of
these 75 patients, 68 were operated before January 2013
and could be studied by echocardiography at one year.
There were no death peri-operative and until one year at
the time of echocardiography among these patients. For
these 68 patients, the follow-up was 100% complete.
In the stented group 64 patients had aortic stenosis.
Of these 64 patients, 46 were operated before January2013 and could have been available for echocardiography
at one year. Among these 46 patients, 36 patients under-
went isolated stented aortic valve replacement with one
peri-operative death. There was no other death among
the remaining 45 patients who were studied by echocar-
diography at one year. For these 45 patients, the follow-
up was 100% complete.
Subgroups of patients with aortic stenosis with or with-
out coronary artery disease were further analyzed for the
peri-operative outcomes and mid-term hemodynamic per-
formances. In contrast to the whole study population,
there was no difference in the risk profile, reflected by
Euroscore, in these subgroups of patients between the
stentless and stented cohorts (Table 2).
Of the 68 stentless patients with aortic stenosis studied
at one year, 55 had isolated full-root aortic valve replace-
ment. Operative and early post-operative data of these
55 patients were compared to those of 36 patients who
underwent isolated stented aortic valve replacement
(Table 3). In these patients, the ischemic time for iso-
lated full-root stentless xenograft implantation was sig-
nificantly longer than that for stented aortic valve
replacement (84.3 ± 9.8 versus 62.3 ± 9.4 minutes, p <
0.0001) (Table 3). Accordingly, the cardiopulmonary by-
pass and operative times were respectively 36 and 55 mi-
nutes longer for the former group. Despite the more
demanding procedure for full-root stentless xenograft
implantation, peri-operative complications and early
death rates were comparable to those for stented aortic
valve replacement (Table 3).
For patients with aortic stenosis, the projected indexed
effective orifice areas (IEOA) based on the effective ori-
fice areas for different sizes of stentless and stented peri-
cardial aortic valves supplied by the manufacturers are
shown in Figure 2 and Table 4. The projected IEOA for
patients in the stentless group was significantly higher
Table 3 Operative and early post-operative data for
isolated procedures in patients with aortic stenosis






N = 55 N = 36
Age, years 62.8 ± 10.9 71.6 ± 10.1 0.0004
Female gender 10(18%) 15(42%) 0.0141
Ejection fraction 51 ± 13 57 ± 8 0.0153
Redo surgery 4(7%) 4(11%) 0.5272
Cross-clamp
time (min)
84.3 ± 9.8 62.3 ± 9.4 0.0001
CPB time (min) 137 ± 34.5 101 ± 27.2 0.0001




Pace maker 1(1.8%) 0 0.4315
Stroke 1(1.8%) 1(3%) 0.7736
Sternal infection 0 0 ns
Early mortality 0 1(3%) 0.2249
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pericardial valve 3–4 mm smaller (Figure 2A). Con-
versely, the projected IEOA for patients in the pericar-
dial stented group was significantly lower than the
calculated IEAO if they had received a full-root stentless
aortic valve 3–4 mm larger (Figure 2B).
In patients with aortic stenosis, the maximum and
mean transvalvular gradients at one year after the oper-
ation were significantly lower for the stentless aortic xe-
nografts as compared to the pericardial stented aortic
valves (Figure 3A and B). In correlation with this obser-
vation, compared to the pre-operative finding, the post-
















Figure 2 Projected versus calculated IEOA in patients with aortic sten
patients in the stentless group (white bars) was compared to the calculated IE
(black bars). B) The projected IEOA for patients in the pericardial stented grou
a full-root stentless aortic valve 3–4 mm larger (white bars). Blocks are meanspatients who received full-root aortic xenografts. In con-
trast, in patients who received pericardial stented aortic
valves, the reduction in the post-operative LVMI at one
year compared to the pre-operative finding did not reach
statistical significance (Figure 4).
Discussion
This study reports a detailed description of the surgical
technique of full-root aortic valve replacement using
stentless aortic xenografts in 180 consecutive patients.
In a subgroup of patients with aortic stenosis, we com-
pared the early clinical outcomes, mid-term transvalvu-
lar gradients and degree of LVMI regression to those of
patients who underwent aortic valve replacement with
stented aortic valves.
In our technique, the proximal (inflow) anastomosis
for full-root implantation of the stentless aortic xeno-
graft is performed using a total of 6 Prolene 4.0 running
sutures (2 running sutures per sinus of Valsalva) without
any reinforcement with pericardial or Teflon strips, as
described by other authors [8-10]. Compared to multiple
simple interrupted sutures [10,11] and a single running
suture [8,9], our use of 6 running sutures allows for a
more controlled and meticulous implantation of the
stentless aortic xenograft at the proximal anastomosis
site. In our whole series of 180 patients, no resternotomy
was necessary for bleeding. Our technique of reimplan-
tation of the coronary arteries allowed us to avoid any
tension on and malalignment of the coronary arteries in
patients. Other authors rotate the stentless xenograft in
a clockwise manner in order to direct the right coronary
ostium of the graft to the non-coronary sinus of the pa-
tient [9]. This rotation necessitates oversewing of the
right coronary ostium of the graft. Our technique of cor-
onary reimplantation also used by the majority of au-
















osis operated before January 2013. A) The projected IEOA for
OA if they had received a stented pericardial valve 3–4 mm smaller
p (black bars) was compared to the calculated IEAO if they had received
and bars are SD values. ***indicates p < 0.001 and ****p < 0.0001.
Table 4 Hemodynamic data for the subgroups of patients
with aortic stenosis with or without associated coronary





n = 68 n = 45
1-year mean gradient (mmHg) 5.7 ± 2.9 13.9 ± 5.3
1-year maximum gradient (mmHg) 10.7 ± 5.7 23.9 ± 9.6
Projected Indexed EOA (cm2/m2) 1.16 ± 0.11 0.92 ± 0.12
Preoperative LVMI (g/m2) 156 ± 16 133 ± 37
1-year LVMI (g/m2) 103 ± 16 124 ± 33
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root replacement using stentless xenografts performed by
a single surgeon [9,11-13]. Involvement of only one sur-
geon eliminates one of the biases of the studies comparing
stented aortic valves to stentless aortic xenografts im-
planted as a full-root or in the sub-coronary position, in-
cluding more than one surgeon and/or center [8,14-18].
As expected from other reports [8], in our patients with
aortic stenosis, the cross-clamp, cardiopulmonary bypass
and operative times were respectively 22, 36 and 55 mi-
nutes longer for isolated full-root aortic replacement by
stentless aortic xenografts compared to isolated standard
stented pericardial aortic valve implantation. Nevertheless,
early morbidity and mortality were not adversely affected
by the prolongation of the ischemic, cardiopulmonary by-
pass and operative times in the full-root stentless group.
In particular, the incidence of re-exploration for bleeding,
complete heart block requiring definitive pace maker im-
plantation, stroke, deep sternal infection or early mortality
were similarly very low in both groups, and compared fa-
vorably to those reported in the STS Adult Cardiac Sur-
gery database [19]. In accordance with our experience,
other authors report that full root replacement using a
stentless bioprosthesis does not increase postoperative
morbidity or mortality of aortic valve replacement [8,9].Figure 3 Post-operative transvalvular gradients in patients with aorti
gradients at one year after the operation for patients in the stentless comp
at one year after the operation for patients in the stentless compared in th
****indicates p < 0.0001.In addition, our study demonstrates that by eliminating
the obstructive element of the stented pericardial aortic
valves due to the sewing ring, the full-root implantation of
stentless aortic xenografts potentially allows the insertion of
an aortic valve 3–4 mm larger in diameter, i.e. two sizes lar-
ger for a given patient. However, this advantage of the
stentless over stented pericardial valves disappears with the
sub-coronary implantation of the former ones. Indeed some
authors report no hemodynamic advantage of the stentless
over stented valves [16-18]. Our results support the hypoth-
esis that the sub-coronary implantation of the stentless
valves in these studies may largely explain this finding. In
our patients with aortic stenosis, full-root stentless aortic
xenograft implantation provided a significantly higher
IEOA than if they had received a stented pericardial valve
3–4 mm smaller. Conversely, in our patients with aortic
stenosis, implantation of stented pericardial valves yielded
significantly lower IEAO than if they had received a full-
root stentless aortic valve 3–4 mm larger. Indeed, at one-
year follow-up, full-root stentless valves of any size had sig-
nificantly lower transvalvular gradients than their stented
pericardial counterparts. This finding accounts for the sig-
nificantly better regression of the left ventricular mass index
in our patients who received full-root stentless valves as
compared to those who underwent aortic valve replacement
with stented pericardial valves. This finding issued from a
retrospective study is in agreement with and supports the
results of the prospective observational study of Fries and
co-workers reporting lower transvalvular gradients at rest
and during exercise as well as better regression of the left
ventricular mass index in patients undergoing full-root 23-
mm stentless versus 23-mm stented aortic valves [20].
Limitations of the study
There are several factors that may influence the regression
of LVH after AVR. However, the effect of many of these
factors on the regression of LVH after AVR remains con-
troversial. Whereas some authors reported no relationc stenosis operated before January 2013. A) Maximum transvalvular
ared in the pericardial stented group. B) Mean transvalvular gradients
e pericardial stented group. Blocks are means and bars are SD values.
Figure 4 Pre- and post-operative LVMI in patients with aortic stenosis operated before January 2013. The left ventricular mass index at
one year after the operation was compared to the pre-operative value in the stented group (left panel) and in the stentless group (right panel)
using the non- parametric Wilcoxon matched-pair signed rank test. Ns, non-significant, and ****indicates p < 0.0001.
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the regression of LVH after AVR [21-24], Lund and co-
workers found that older age (included in a pre-operative
risk model) was indirectly associated with incomplete re-
gression of LVH after AVR [25].
The impact of the gender is also debated. Kühl and co-
workers reported that the regression of LVH after AVR
was not related to gender [23] whilst Gelsomino and co-
workers found that the male gender negatively affected
the regression of LVH after AVR [26]. In the latter study,
age did not affect the regression of LVH after AVR [26].
In our study despite the larger number of male patients
in the stentless compared to the stented group, the re-
gression of LVH after AVR was better.
Further, on one hand Tasca et al. reported a higher pre-
operative LVMI to be predictor of a greater regression of
LVH after AVR [24]. On the other hand Lund et al. studied
transmural biopsies taken during AVR and found that the
regression of LVMI was inversely related to ultrastructural
changes of advanced myocardial disease represented by
muscle cell diameter, nucleus volume, percent fibrosis,
muscle cell and fibrous tissue mass index at the time of
AVR. They concluded that the extent of LVMI regression
seemed to be related to the presence of irreversible myocar-
dial damage [27]. In this regard, patients with higher pre-
operative LVMI are not likely to have less irreversible myo-
cardial damage than those with lower pre-operative LVMI.
This finding of Lund and co-workers does not support the
notion that patients with higher pre-operative LVMI would
necessarily show a greater regression of LVH after AVR.
In the present study, we elected to use the projected
IEOA rather than the postoperative IEAO to predict PPMfor several reasons. The IEOA measured by Doppler echo-
cardiography after operation may be influenced by several
factors (including subvalvular geometry, the orientation of
the prosthesis, the nonuniformity of the subvalvular vel-
ocity profile, and measurement errors) [28]. In contrast,
the projected IEOA is not affected by these factors and is
not operator dependent. And more importantly, it can be
calculated at the time of operation to predict PPM and can
thus be used to prevent PPM as shown in previous studies
[29,30]. In this regard, many studies that have analyzed the
impact of PPM on postoperative outcomes have used the
projected IEOA to define PPM. These reports [24,31,32]
have further demonstrated that the projected IEOA corre-
lates well with postoperative resting and exercise transpros-
thetic gradients and that it can thus be used to identify the
patients who might have a high gradient on the basis
of PPM.
Conclusion
In conclusion, despite the limitations lying on the retro-
spective character of this study, we may submit that full-
root stentless aortic valve replacement with xenografts can
be performed without adversely affecting the early mor-
bidity or mortality in patients operated on for aortic valve
stenosis provided that the coronary ostia are not heavily
calcified. The additional time necessary for the full-root
implantation of the stentless valve compared to the im-
plantation of the pericardial stented valves is therefore not
detrimental to the early clinical outcomes and is largely
rewarded in patients with aortic stenosis by lower trans-
valvular gradients at mid-term and a better regression of
their left ventricular mass index.
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